Department of Radiology, Nagoya University Graduate School of Medicine, Shouwa-ku, Japan.
Cancer Imaging. 2012 Jun 29;12(1):187-93. doi: 10.1102/1470-7330.2012.0018.
To compare pathological prognostic factors of small lung adenocarcinomas with findings of contrast-enhanced dynamic computed tomography (CT) scans.
We evaluated 108 patients with lung adenocarcinomas ≤ 30 mm in diameter who underwent dynamic CT scans (80-96 ml of contrast material, 2.5-3 ml/s injection) and tumor resections. Attenuation values of both the early phase (20-36 s after injection) and delayed phase (91-95 s) of enhanced CT minus baseline plain CT attenuation were defined as ΔEarly and ΔDelay. The early enhancement ratio was defined as ΔEarly/ΔDelay×100 (%). We statistically compared the early enhancement ratios between the presence and absence of each pathological finding (lymph node metastasis, lymphatic permeation, vascular invasion, and pleural involvement). Patients were divided into 2 groups based on early enhancement ratios: ratio ≥50% (n = 41) and ratio <50% (n = 67) and we statistically compared these 2 groups.
The early enhancement ratios in the group with lymph node metastasis, lymphatic permeation, and vascular invasion were significantly lower than in the group without these findings (24.9% vs 48.6%; P < 0.001, 30.0% vs 47.5%; P = 0.002, and 26.5% vs 47.0%; P = 0.002, respectively). Lymph node metastasis, lymphatic permeation, and vascular invasion were significantly more frequent in tumors with a ratio <50% than in tumors with ratio ≥50% (P < 0.001, P = 0.008, and P = 0.005, respectively).
There was a significant correlation between the early enhancement ratio of enhanced dynamic CT and the pathological prognostic factors in small lung adenocarcinomas.
比较小肺腺癌的病理学预后因素与对比增强动态 CT(CT)扫描的结果。
我们评估了 108 例直径≤30mm 的肺腺癌患者,他们均进行了动态 CT 扫描(注射 80-96ml 造影剂,2.5-3ml/s 注射速度)和肿瘤切除术。增强 CT 的早期相(注射后 20-36s)和延迟相(91-95s)减去基线平扫 CT 衰减值定义为ΔEarly 和ΔDelay。早期增强率定义为ΔEarly/ΔDelay×100(%)。我们对存在和不存在每种病理发现(淋巴结转移、淋巴渗透、血管侵犯和胸膜侵犯)时的早期增强率进行了统计学比较。根据早期增强率,患者被分为两组:比值≥50%(n=41)和比值<50%(n=67),并对这两组进行了统计学比较。
有淋巴结转移、淋巴渗透和血管侵犯的组的早期增强率明显低于无这些发现的组(24.9%比 48.6%;P<0.001,30.0%比 47.5%;P=0.002,26.5%比 47.0%;P=0.002)。比值<50%的肿瘤中淋巴结转移、淋巴渗透和血管侵犯的发生率明显高于比值≥50%的肿瘤(P<0.001,P=0.008,P=0.005)。
增强动态 CT 的早期增强率与小肺腺癌的病理学预后因素之间存在显著相关性。